Deerfield Management Company »

Bright Minds Biosciences shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $21M 283k 72.97

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Brookdale Sr Living Note 3.500%10/1 (Principal)
Cogent Biosciences (COGT)
Praxis Precision Medicines I Com New (PRAX)
Viatris (VTRS)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Arrowhead Pharmaceuticals In Note 1/1 (Principal)
Celcuity (CELC)
Centene Corporation (CNC)
Larimar Therapeutics (LRMR)
Brookdale Senior Living (BKD)
Vera Therapeutics Cl A (VERA)
Ionis Pharmaceuticals (IONS)

View all positions for Deerfield Management Company

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
BlackRock
Vivo Capital
Braidwell
Vestal Point Capital
Adage Capital Partners GP
Perceptive Advisors
Balyasny Asset Management
Deerfield Management Company
Driehaus Capital Management
RA Capital Management
Dr. Jeffrey R. Jay, M.D.
MPM Oncology Impact Management
Ikarian Capital

View all funds holding Bright Minds Biosciences